PNC Financial Services Group Inc. grew its holdings in Genpact Limited (NYSE:G – Free Report) by 4.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,468 shares of the business services provider’s stock after purchasing an additional 550 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Genpact were worth $621,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in G. Advisors Asset Management Inc. increased its position in Genpact by 3.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 6,885 shares of the business services provider’s stock valued at $270,000 after acquiring an additional 226 shares in the last quarter. CIBC Asset Management Inc increased its position in Genpact by 5.5% in the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider’s stock valued at $244,000 after acquiring an additional 297 shares in the last quarter. Tealwood Asset Management Inc. increased its position in Genpact by 1.4% in the 4th quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider’s stock valued at $1,059,000 after acquiring an additional 339 shares in the last quarter. UMB Bank n.a. increased its position in Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after acquiring an additional 433 shares in the last quarter. Finally, Blue Trust Inc. increased its position in Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock valued at $217,000 after acquiring an additional 441 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Stock Up 0.2 %
Genpact stock opened at $50.47 on Wednesday. The company’s 50 day simple moving average is $49.86 and its 200 day simple moving average is $44.46. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of 17.77, a PEG ratio of 1.84 and a beta of 1.16. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.
Genpact Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.35%. This is a positive change from Genpact’s previous quarterly dividend of $0.15. Genpact’s payout ratio is presently 23.94%.
Insider Buying and Selling at Genpact
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the stock. Mizuho raised their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC lifted their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Finally, TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $48.44.
Get Our Latest Research Report on Genpact
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- Investing in the High PE Growth Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Must-Own Stocks to Build Wealth This Decade
- Which Wall Street Analysts are the Most Accurate?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.